期刊的影响因子--文章列表

期刊文章列表
Jinghui Zhang^1,2，Jiajun Fan^2,3，Xian Zeng^2,3，Mingming Nie¹，Jingyun Luan^2,3，Yichen Wang^2,3，Dianwen Ju^2,3，Kai Yin¹（Department of Gastrointestinal Surgery，Changhai Hospital，Second Military Medical University；Department of Biological Medicines，Fudan University School of Pharmacy；Shanghai Engineering Research Center of Immunotherapeutics）.Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment[J].Acta Pharmaceutica Sinica B,2021,第3期 Tailin He¹，Jialin Shang²，Chenglong Gao¹，Xin Guan¹，Yingyi Chen²，Liwen Zhu³，Luyong Zhang¹，Cunjin Zhang³，Jian Zhang²，Tao Pang¹（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Drug Screening，Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases，China Pharmaceutical University；Medicinal Bioinformatics Center，Shanghai Jiao Tong University School of Medicine；Department of Neurology of Drum Tower Hospital，Medical School and the State Key Laboratory of Pharmaceutical Biotechnology，Nanjing University）.A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2/FOXC1 axis[J].Acta Pharmaceutica Sinica B,2021,第3期 Yuan Fang¹，Chao Yang²，Zhiqiang Yu³，Xiaochuan Li⁴，Qingchun Mu⁴，Guochao Liao¹，Bin Yu^5,6（Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People’s Republic of China，International Institute for Translational Chinese Medicine，Guangzhou University of Chinese Medicine；Institute of Innovation & Application，Zhejiang Ocean University；School of Pharmaceutical Sciences，Southern Medical University；The People’s Hospital of Gaozhou；School of Pharmaceutical Sciences，Zhengzhou University；State Key Laboratory of Natural Medicines，China Pharmaceutical University）.Natural products as LSD1 inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2021,第3期 Panxia Wang¹，Minghui Wang¹，Yuehuai Hu¹，Jianxing Chen¹，Yanjun Cao¹，Cui Liu¹，Zhongkai Wu²，Juan Shen³，Jing Lu¹，Peiqing Liu^1,4,5（School of Pharmaceutical Sciences，Sun Yat-sen University；Department of Cardiac Surgery，First Affiliated Hospital，Sun Yat-sen University；Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances，Guangdong Pharmaceutical University；Guangdong Provincial Key Laboratory of New Drug Design and Evaluation，Sun Yat-sen University；Guangdong Provincial Engineering Laboratory of Druggability and New Drugs Evaluation）.Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression[J].Acta Pharmaceutica Sinica B,2021,第3期 Qiu Sun，Mengyuan Huang，Yuquan Wei（State Key Laboratory of Biotherapy，Cancer Center，West China Hospital，Sichuan University and Collaborative Innovation Center for Biotherapy）.Diversity of the reaction mechanisms of SAM-dependent enzymes[J].Acta Pharmaceutica Sinica B,2021,第3期 Zhiru Wang^1,,,4；Wenting Kang¹；Ouwen Li¹；Fengyu Qi¹；Junwei Wang¹；Yinghua You¹；Pengxing He¹；Zhenhe Suo⁴；Yichao Zheng¹；Hong-Min Liu¹（School of Pharmaceutical Sciences,Zhengzhou University；Co-Innovation Center of Henan Province for New Drug R&D and Preclinical Safety；State Key Laboratory of Esophageal Cancer Prevention and Treatment,Key Laboratory of Advanced Drug Preparation Technologies,Ministry of Education of China；Department of Pathology,the Norwegian Radium Hospital,Oslo University Hospital；Department of Pathology,Institute for Clinical Medicine,Faculty of Medicine,University of Oslo）.Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing[J].Acta Pharmaceutica Sinica B,2021,第3期 Pei Wang¹，Fang Wang^1,2,3,4，Lan Ni¹，Pengfei Wu^1,3，Jianguo Chen^1,2,3,4（Department of Pharmacology，School of Basic Medicine，Tongji Medical College，Huazhong University of Science and Technology；Key Laboratory of Neurological Diseases (HUST)，Ministry of Education of China；The Key Laboratory for Drug Target Researches and Pharmacodynamic Evaluation of Hubei Province；Laboratory of Neuropsychiatric Diseases，the Institute of Brain Research，Huazhong University of Science and Technology）.Targeting redox-altered plasticity to reactivate synaptic function：A novel therapeutic strategy for cognitive disorder[J].Acta Pharmaceutica Sinica B,2021,第3期 Pingping Luo¹，Ming Zheng²，Rui Zhang¹，Hong Zhang²，Yingxia Liu³，Wei Li⁴，Xiaoming Sun⁵，Qian Yu⁶，George L.Tipoe⁶，Jia Xiao^1,6（Clinical Medicine Research Institute，the First Affiliated Hospital of Jinan University；Department of Interventional Surgery，the First Affiliated Hospital of Jinan University；State Key Discipline of Infectious Diseases，Department of Infectious Diseases，Shenzhen Third People’s Hospital；Faculty of Pharmaceutical Sciences，Toho University；School of Integrative Pharmacy，Institute of Integrative Pharmaceutical Research，Guangdong Pharmaceutical University；School of Biomedical Sciences，Li Ka Shing Faculty of Medicine，the University of Hong Kong）.S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling[J].Acta Pharmaceutica Sinica B,2021,第3期 Peng Liu¹，Xin Xie²，Miao Liu¹，Shuo Hu^3,4，Jinsong Ding¹，Wenhu Zhou^1,2,4（Xiangya School of Pharmaceutical Sciences，Central South University；School of Pharmaceutical Sciences，Gannan Medical University；Department of Nuclear Medicine，Xiangya Hospital，Central South University；Key Laboratory of Biological Nanotechnology of National Health Commission）.A smart MnO₂-doped graphene oxide nanosheet for enhanced chemo-photodynamic combinatorial therapy via simultaneous oxygenation and glutathione depletion[J].Acta Pharmaceutica Sinica B,2021,第3期 Yihui Song¹，Min Zhao¹，Yahong Wu²，Bin Yu¹，Hong-Min Liu¹（School of Pharmaceutical Sciences & Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education，Zhengzhou University；School of Life Sciences，Zhengzhou University）.A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors[J].Acta Pharmaceutica Sinica B,2021,第3期 Xiaowei Wu¹，Mengdi Dai^2,3，Rongrong Cui⁴，Yulan Wang¹，Chunpu Li¹，Xia Peng²，Jihui Zhao^1,3，Bao Wang¹，Yang Dai²，Dan Feng¹，Tianbiao Yang¹，Hualiang Jiang^1,4，Meiyu Geng²，Jing Ai^2,3，Mingyue Zheng^1,3,4，Hong Liu¹（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Division of Anti-Tumor Pharmacology，State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；University of Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine）.Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors[J].Acta Pharmaceutica Sinica B,2021,第3期 Xianyan Qin^1,2，Yingying Xu¹，Xu Zhou^1,3，Tao Gong¹，Zhi-Rong Zhang¹，Yao Fu¹（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University；Key Laboratory of Advanced Technologies of Materials，Ministry of Education and School of Materials Science and Engineering，Southwest Jiaotong University；Sichuan Provincial Orthopedic Hospital）.An injectable micelle-hydrogel hybrid for localized and prolonged drug delivery in the management of renal fibrosis[J].Acta Pharmaceutica Sinica B,2021,第3期 Yue Gao¹，Shicheng Fan¹，Hua Li²，Yiming Jiang¹，Xinpeng Yao¹，Shuguang Zhu²，Xiao Yang¹，Ruimin Wang¹，Jianing Tian¹，Frank J.Gonzalez³，Min Huang¹，Huichang Bi¹（Guangdong Provincial Key Laboratory of New Drug Design and Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；Department of Hepatic Surgery，the Third Affiliated Hospital，Sun Yat-sen University；Laboratory of Metabolism，Center for Cancer Research，National Cancer Institute）.Constitutive androstane receptor induced-hepatomegaly and liver regeneration is partially via yes-associated protein activation[J].Acta Pharmaceutica Sinica B,2021,第3期 Lei Wang^1,2，Mary C.Casey³，Sanjeev Kumar V.Vernekar¹，Rajkumar Lalji Sahani¹，Karen A.Kirby⁴，Haijuan Du⁴，Huanchun Zhang⁴，Philip R.Tedbury⁴，Jiashu Xie¹，Stefan G.Sarafianos⁴，Zhengqiang Wang¹（Center for Drug Design，College of Pharmacy，University of Minnesota；Department of Pharmaceutical Sciences，School of Chemical Engineering，Dalian University of Technology；Department of Molecular Microbiology and Immunology，University of Missouri School of Medicine，Christopher S.Bond Life Sciences Center；Laboratory of Biochemical Pharmacology，Department of Pediatrics，Emory University School of Medicine）.Novel PF74-like small molecules targeting the HIV-1 capsid protein：Balance of potency and metabolic stability[J].Acta Pharmaceutica Sinica B,2021,第3期 Ting Zhang^1,2，James Zhenggui Tang³，Xiaofan Fei¹，Yanping Li⁴，Yi Song¹，Zhiyong Qian⁵，Qiang Peng²（Department of Pharmacy，West China Hospital，Sichuan University；State Key Laboratory of Oral Diseases，National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology，Sichuan University；Research Institute in Healthcare Science，Faculty of Science and Engineering，School of Pharmacy，University of Wolverhampton；Laboratory of Clinical Pharmacy and Adverse Drug Reaction，West China Hospital of Sichuan University；State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，Sichuan University and Collaborative Innovation Center）.Can nanoparticles and nano-protein interactions bring a bright future for insulin delivery?[J].Acta Pharmaceutica Sinica B,2021,第3期 Fanxun Zeng¹，Shiliang Li²，Guantian Yang¹，Yating Luo²，Tiantian Qi²，Yingfan Liang²，Tingyuan Yang²，Letian Zhang¹，Rui Wang²，Lili Zhu²，Honglin Li²，Xiaoyong Xu¹（Shanghai Key Laboratory of Chemical Biology，School of Pharmacy，East China University of Science &Technology；Shanghai Key Laboratory of New Drug Design，State Key Laboratory of Bioreactor Engineering，School of Pharmacy，East China University of Science & Technology）.Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis[J].Acta Pharmaceutica Sinica B,2021,第3期 Di Wang¹，Danting Li¹，Yuxin Zhang²，Jie Chen¹，Ying Zhang¹，Chuyao Liao¹，Siyuan Qin¹，Yuan Tian¹，Zunjian Zhang¹，Fengguo Xu¹（Key Laboratory of Drug Quality Control and Pharmacovigilance (Ministry of Education)，State Key Laboratory of Natural Medicine，China Pharmaceutical University；Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School）.Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage[J].Acta Pharmaceutica Sinica B,2021,第3期 Yamin Gao^1,2,3，H.M.Adnan Hameed^1,2,3，Yang Liu^1,4，Lingmin Guo^1,2,3，Cuiting Fang^1,2,3，Xirong Tian^1,4，Zhiyong Liu^1,3，Shuai Wang^1,2,3，Zhili Lu^1,3，Md Mahmudul Islam^1,2,3，Tianyu Zhang^1,2,3（State Key Laboratory of Respiratory Disease，Guangzhou Institutes of Biomedicine and Health，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Guangdong-Hong Kong-Macao Joint Laboratory of Respiratory Infectious Diseases，Guangzhou Institutes of Biomedicine and Health，Chinese Academy of Sciences；Institute of Physical Science and Information Technology，Anhui University）.Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans[J].Acta Pharmaceutica Sinica B,2021,第3期 Yuanyuan Chen，Zhaojun Li，Xiaoguang Chen，Sen Zhang（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences，Peking Union Medical College）.Long non-coding RNAs：From disease code to drug role[J].Acta Pharmaceutica Sinica B,2021,第2期 David Dolivo¹，Pamela Weathers²，Tanja Dominko²（Department of Surgery，Northwestern University-Feinberg School of Medicine；Department of Biology and Biotechnology，Worcester Polytechnic Institute）.Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics[J].Acta Pharmaceutica Sinica B,2021,第2期 Jianfeng Wang¹，Xiaomao Yin¹，Wei He²，Wei Xue¹，Jin Zhang¹，Yiran Huang¹（Department of Urology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University；Department of Pathology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University）.SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis[J].Acta Pharmaceutica Sinica B,2021,第2期 Xu Jing^1,2，Dandan Ren^1,3，Fei Gao²，Ye Chen¹，Xiao Wu⁴，Yue Han¹，Qingsheng Han¹，Liang Li¹，Xiaojie Wang¹，Wei Tang⁵，Yan Zhang¹（Department of Pharmacology，School of Basic Medical Science，Shandong University；Department of Clinical Laboratory，the Second Hospital of Shandong University；Chengda Biology Co.，Ltd.；The Key Laboratory of Cardiovascular Remodeling and Function Research，Department of Cardiology，Qilu Hospital of Shandong University；Department of Microbiology，School of Basic Medical Science，Shandong University）.Gene deficiency or pharmacological inhibition of PDCD4-mediated FGR signaling protects against acute kidney injury[J].Acta Pharmaceutica Sinica B,2021,第2期 Zhiming Zhangy，Chenlu Huangy，Li Zhang，Qing Guo，Yu Qin，Fan Fan，Boxuan Li，Bao Xiao，Dunwan Zhu，Linhua Zhang（Tianjin Key Laboratory of Biomedical Materials，Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College）.pH-sensitive and bubble-generating mesoporous silica-based nanoparticles for enhanced tumor combination therapy[J].Acta Pharmaceutica Sinica B,2021,第2期 Qian Wei¹，Jian Bai¹，Daojiang Yan¹，Xiuqi Bao¹，Wenting Li²，Bingyu Liu¹，Dan Zhang¹，Xiangbing Qi²，Dequan Yu¹，Youcai Hu¹（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Institute of Biological Sciences）.Genome mining combined metabolic shunting and OSMAC strategy of an endophytic fungus leads to the production of diverse natural products[J].Acta Pharmaceutica Sinica B,2021,第2期 Tingting Jiang¹，Guan Wang¹，Yao Liu¹，Lu Feng¹，Meng Wang¹，Jie Liu¹，Yi Chen²，Liang Ouyang¹（State Key Laboratory of Biotherapy and Cancer Center，West China Hospital，and Collaborative Innovation Center of Biotherapy，Sichuan University；State Key Laboratory of Biotherapy and Cancer Center and Department of Gastrointestinal Surgery，West China Hospital，Sichuan University，and Collaborative Innovation Center for Biotherapy）.Development of small-molecule tropomyosin receptor kinase(TRK) inhibitors for NTRK fusion cancers[J].Acta Pharmaceutica Sinica B,2021,第2期 Shaojun Peng^1,2，Boshu Ouyang³，Yongjie Xin¹，Wei Zhao¹，Shun Shen⁴，Meixiao Zhan¹，Ligong Lu¹（Zhuhai Precision Medical Center，Zhuhai Interventional Medical Center，Zhuhai People’s Hospital(Zhuhai Hospital Affiliated with Jinan University)；The Institute for Translational Nanomedicine，Shanghai East Hospital，Tongji University School of Medicine；Central Laboratory，First Affiliated Hospital，Institute of Integrative Medicine，Dalian Medical University；Zhejiang Cancer Hospital，Institute (College) of Cancer Research）.Hypoxia-degradable and long-circulating zwitterionic phosphorylcholine-based nanogel for enhanced tumor drug delivery[J].Acta Pharmaceutica Sinica B,2021,第2期首页上一页 7 8 9 10 11 下一页尾页共有11页，转到页

期刊文章列表